Literature DB >> 2856879

Effect of exogenous somatostatin infusion on gastrointestinal blood flow and hormones in the conscious dog.

B A Price, B M Jaffe, M J Zinner.   

Abstract

The purpose of this study was to investigate the effects of intravenous somatostatin infusion on gastrointestinal blood flow and hormone release in conscious dogs. Gastric, duodenal, jejunal, and pancreatic blood flows, quantitated using radioactive microspheres, were significantly decreased during somatostatin infusion (200 and 500 ng/kg min), resulting in an overall 30% reduction in summed portal blood flow. Fasting blood levels of glucose fell an average of 10 mg/dl. Immunoreactive insulin, gastrin, glucagon, and pancreatic polypeptide were all profoundly suppressed by somatostatin infusion. Our studies provide one possible explanation for somatostatin's apparent effectiveness in the control of upper gastrointestinal hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2856879     DOI: 10.1016/s0016-5085(85)80136-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

Review 1.  Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases.

Authors:  L J O'Donnell; M J Farthing
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

Review 2.  Somatostatin in portal hypertension.

Authors:  J S Morgan; R J Groszmann
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

Review 3.  Somatostatin.

Authors:  S R Bloom; J M Polak
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

Review 4.  Somatostatin and analogues in the treatment of cancer. A review.

Authors:  B M Evers; D Parekh; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

5.  Effect of a somatostatin analogue (SMS 201-995) on hemodynamics and glucagon secretion in cirrhotic rats.

Authors:  N Hori; T Okanoue; Y Sawa; T Mori; K Kashima
Journal:  Gastroenterol Jpn       Date:  1993-04

6.  Effects of somatostatin (SMS) on pancreatic microcirculation.

Authors:  T Plusczyk; D Rathgeb; S Westermann; G Feifel
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

7.  Somatostatin attenuates microcirculatory impairment in acute sodium taurocholate-induced pancreatitis.

Authors:  T Plusczyk; D Rathgeb; S Westermann; G Feifel
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

8.  Stimulated pancreatic exocrine secretion does not require pancreatic hyperemia in rats. Potential cholinergic role.

Authors:  R L Conter; J L Washington; G L Kauffman
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

9.  Effects of long-acting somatostatin analog (SMS 201-995) on eicosanoid synthesis and survival in rats with acute necrotizing pancreatitis.

Authors:  B van Ooijen; C J Tinga; W J Kort; F J Zijlstra; S W Lamberts; J H Wilson
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

10.  Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors.

Authors:  Mariam Alatrach; Nitchakarn Laichuthai; Robert Martinez; Christina Agyin; Ali Muhammed Ali; Hussein Al-Jobori; Olga Lavynenko; John Adams; Curtis Triplitt; Ralph DeFronzo; Eugenio Cersosimo; Muhammad Abdul-Ghani
Journal:  Diabetes       Date:  2020-01-08       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.